Shabir Madhi to Immunization Programs
This is a "connection" page, showing publications Shabir Madhi has written about Immunization Programs.
Connection Strength
5,381
-
The role of National Immunization Technical Advisory Groups (NITAG) in strengthening health system governance: Lessons from three middle-income countries-Argentina, Jordan, and South Africa (2017-2018). Vaccine. 2020 10 21; 38(45):7118-7128.
Score: 0,675
-
Factors influencing access of pregnant women and their infants to their local healthcare system: a prospective, multi-centre, observational study. BMC Pregnancy Childbirth. 2018 01 15; 18(1):29.
Score: 0,561
-
Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa. Clin Infect Dis. 2016 May 01; 62 Suppl 2:S188-95.
Score: 0,498
-
The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience. Hum Vaccin Immunother. 2016; 12(2):314-25.
Score: 0,487
-
Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme. S Afr Med J. 2014 Mar; 104(3 Suppl 1):228-34.
Score: 0,429
-
Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine. 2012 Sep 07; 30 Suppl 3:C21-7.
Score: 0,387
-
Will the Decade of Vaccines mean business as usual? Lancet. 2011 Jul 30; 378(9789):382-5.
Score: 0,355
-
Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining? Lancet Infect Dis. 2006 Mar; 6(3):150-61.
Score: 0,246
-
Vaccine stock-outs: A preventable health facility obstacle contributing to missed vaccinations in South African children. Vaccine. 2025 Jan 25; 45:126583.
Score: 0,226
-
Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization. Expert Rev Vaccines. 2020 04; 19(4):383-393.
Score: 0,164
-
Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014. Vaccine. 2018 11 12; 36(47):7231-7237.
Score: 0,138
-
Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006-2014. Bull World Health Organ. 2017 Sep 01; 95(9):618-628.
Score: 0,135
-
Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. 2017 06 05; 35(25):3303-3308.
Score: 0,133
-
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. 2017 06 05; 35(25):3295-3302.
Score: 0,133
-
The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa. Vaccine. 2016 07 19; 34(33):3713-4.
Score: 0,126
-
Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference. Pan Afr Med J. 2016; 23:53.
Score: 0,123
-
Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr Infect Dis J. 2013 Dec; 32(12):1359-64.
Score: 0,105
-
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health. 2012 Jul 31; 12:578.
Score: 0,096
-
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J. 2011; 8:24.
Score: 0,087
-
The National Advisory Group on Immunization (NAGI) of the Republic of South Africa. Vaccine. 2010 Apr 19; 28 Suppl 1:A31-4.
Score: 0,082
-
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case. Vaccine. 2022 03 15; 40(12):1681-1690.
Score: 0,046
-
Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ?5 years in Cameroon, 2011-2018. PLoS One. 2021; 16(4):e0250010.
Score: 0,044
-
Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines. Vaccine. 2017 10 13; 35(43):5734-5737.
Score: 0,034
-
Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. Vaccine. 2010 Feb 17; 28(7):1677-83.
Score: 0,020
-
A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis. 2009 Nov 01; 200 Suppl 1:S57-62.
Score: 0,020
-
Pneumococcal vaccination in developing countries. Lancet. 2006 Jun 10; 367(9526):1880-2.
Score: 0,016
-
Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. Pediatr Infect Dis J. 2004 Sep; 23(9):842-7.
Score: 0,014